Phospholipid metabolism normalization

Phospholipid metabolism normalization" is not a specific molecule, enzyme, receptor, or other canonical therapeutic target. Instead, it refers to the set of biological processes or therapeutic strategies aiming to restore the normal balance and distribution of phospholipids within cellular membranes, organelles, or in systemic metabolism[4][7]. Numerous enzymes, transporters, and regulatory proteins (such as choline kinase, phospholipase A2, CDP-choline pathway enzymes, and others) are involved in phospholipid metabolism, and any of them could be therapeutic targets depending on disease context[4][7]. However, the term, as stated, is too broad and does not refer to one molecular entity but rather an outcome or a pathway function.